Our Team

Early Access Care team members are dedicated to the unique needs of pre-approval access to investigational drug products. Our staff are multi-disciplinary with expertise in strategy, design, and operational implementation of global pre-approval access programs.

With extensive experience in compassionate use / expanded access, clinical R&D, and full development, Early Access Care understands what is needed to successfully develop drug products and will work collaboratively to develop and implement the right program to meet your company’s compassionate use / expanded access needs.

Anne B. Cropp, Pharm.D., BS Chief Scientific Officer
Alita Hassan, MPH Vice President, Early Access Programs
William Leidt, BA Director of Technology
John W. Cropp, PhD, MS, MBA CEO and SVP of Technology
Laurie Reynolds, BS Director, Early Access Programs
Judy Schomer Early Access Operations Associate
Karen Reilly, BS, MPH Executive Director, Data Management and Solutions
Nancy J. Hayden Clinical Records Manager and Controlled Document Specialist
Sarah Alummootil, BS, MS Associate Director, Early Access Programs
Johanna Hancock, RN Director, Early Access Programs
Brittany Mickolichek, RN Sr. Associate Director, Early Access Programs
Suzanne Noeding Clinical Records Manager and Controlled Document Specialist
Cecelia A. Cropp, BS Expanded Access Assistant
Kim Thompson, BS, MS Associate Director, Early Access Programs

Want to learn more about our Expanded Access Capabilities?